According to Galectin Therapeutics's latest financial reports the company's current earnings (TTM) are -โฌ39.97 M. In 2023 the company made an earning of -โฌ37.06 M a decrease over its 2022 earnings that were of -โฌ35 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.